These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19302906)

  • 61. Reactions to Eprex's adverse reactions.
    Sharma B; Ryan MH; Boven K
    Nat Biotechnol; 2006 Oct; 24(10):1199-200; author reply 1200. PubMed ID: 17033648
    [No Abstract]   [Full Text] [Related]  

  • 62. Biosimilars: it's not as simple as cost alone.
    Roger SD; Goldsmith D
    J Clin Pharm Ther; 2008 Oct; 33(5):459-64. PubMed ID: 18834359
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Quality control in the pharmacy].
    Cohen EH
    Pharm Weekbl; 1968 Apr; 103(17):472-85. PubMed ID: 5665059
    [No Abstract]   [Full Text] [Related]  

  • 64. Interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.
    Villalobos AP; Gunturi SR; Heavner GA
    Pharm Res; 2005 Jul; 22(7):1186-94. PubMed ID: 16028020
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Counterfeit Procrit.
    FDA Consum; 2003; 37(3):5. PubMed ID: 12793379
    [No Abstract]   [Full Text] [Related]  

  • 66. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies.
    Taylor RB; Shakoor O; Behrens RH; Everard M; Low AS; Wangboonskul J; Reid RG; Kolawole JA
    Lancet; 2001 Jun; 357(9272):1933-6. PubMed ID: 11425415
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anemia and response to epoetin alfa: the cause of anemia matters!
    Dharmarajan TS
    J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607
    [No Abstract]   [Full Text] [Related]  

  • 68. Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates.
    Calhoun DA; Juul SE; McBryde EV; Veerman MW; Christensen RD
    Ann Pharmacother; 2000 Nov; 34(11):1257-61. PubMed ID: 11098337
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Follow-on biologics: challenges of the "next generation".
    Schellekens H
    Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv31-36. PubMed ID: 15827057
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India.
    Seear M; Gandhi D; Carr R; Dayal A; Raghavan D; Sharma N
    J Clin Pharm Ther; 2011 Aug; 36(4):488-95. PubMed ID: 21729113
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia.
    Tzekova V; Mihaylov G; Elezovic I; Koytchev R;
    Curr Med Res Opin; 2009 Jul; 25(7):1689-97. PubMed ID: 19505200
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of actual and stated concentrations of pharmaceuticals manufactured in Mexico.
    Schwertner HA; Storrow AB
    Clin Ther; 2005 May; 27(5):609-15. PubMed ID: 15978310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. How bio-questionable are the different recombinant human erythropoietin copy products in Thailand?
    Halim LA; Brinks V; Jiskoot W; Romeijn S; Praditpornsilpa K; Assawamakin A; Schellekens H
    Pharm Res; 2014 May; 31(5):1210-8. PubMed ID: 24258097
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy.
    Christodoulou C; Dafni U; Aravantinos G; Koutras A; Samantas E; Karina M; Janinis J; Papakostas P; Skarlos D; Kalofonos HP; Fountzilas G
    Anticancer Res; 2009 Feb; 29(2):693-702. PubMed ID: 19331224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia.
    Khan MH; Okumura J; Sovannarith T; Nivanna N; Akazawa M; Kimura K
    Trop Med Int Health; 2010 May; 15(5):639-44. PubMed ID: 20214756
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials.
    Gaudiano MC; Di Maggio A; Cocchieri E; Antoniella E; Bertocchi P; Alimonti S; Valvo L
    Malar J; 2007 Feb; 6():22. PubMed ID: 17316432
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Laboratory trend analyses and proactive adjustments to minimize the need for holding epoetin alfa doses.
    Breiterman-White R; Reznicek J
    Nephrol Nurs J; 2008; 35(6):577-81, 600. PubMed ID: 19260609
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amgen warns of fake Epogen vials in U.S.
    Nephrol News Issues; 2002 Jun; 16(7):10. PubMed ID: 12073379
    [No Abstract]   [Full Text] [Related]  

  • 79. [Stability of antibiotics in disks as one of the indicators of their quality].
    Galkina TP; Khvoshchevskaia IN; Rezvan SP; Chaĭkovskaia SM
    Antibiotiki; 1984 Nov; 29(11):806-10. PubMed ID: 6524879
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The oxidation of methionine-54 of epoetinum alfa does not affect molecular structure or stability, but does decrease biological activity.
    Labrenz SR; Calmann MA; Heavner GA; Tolman G
    PDA J Pharm Sci Technol; 2008; 62(3):211-23. PubMed ID: 18661870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.